Previous data indicate that specific panels of serum miRNAs could represent prognostic markers for CRC, comparable with traditional markers, including carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), or for the detection of CRC patients with distant metastasis [11]. Here, CEACAM5 is linked to colorectal carcinoma.